NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hedros Biotechnology

Hedros Biotechnology

Private
North CarolinaHealthcare & Life Scienceshttps://www.hedros.bio/

Last Round

Debt

May 28, 2024

Total Funding Raised

$425,000

Company Overview

Hedros Biotechnology is a biotechnology company that operates a research platform providing bacteriophages to fight bacterial infections, with a focus on disease control in aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

bacteriophage therapyphage therapyaquaculture healthantibiotic alternativephage cocktailsshrimp farmingAHPND treatmentAHPNDphage discoveryaquatechAI drug discoveryantimicrobial resistanceanimal healthphage development platformvibriosis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hedros Biotechnology Comparables

Compare Hedros Biotechnology with similar companies based on industry and business-model similarity.

Hedros Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Hedros Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 28, 2024
AcceleratorJul 6, 2023
AcceleratorJun 26, 2023
View all Funding Rounds

Hedros Biotechnology Investors

Notable investors and investment history

Hedros Biotechnology investors
InvestorRounds
North Carolina Biotechnology CenterDebt
Hatch BlueAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2024

    $200K debt round from North Carolina Biotechnology Center

  • Jul 6, 2023

    Accelerator round led by Hatch Blue.

View all signals

Hedros Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hedros Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hedros Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorth Carolina
Year Founded2023
Last FundingMay 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.